2018Yanwaishang zhiye yanbing zazhiRequires access

Efficacy of transscleral laser cyclophotocoagulation for the treatment of refractory glaucoma

Yanhui Bai, Jingmin Dong

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Methods The data of 48 eyes of 48 refractory glaucoma patients were enrolled and analyzed retrospectively. All eyes underwent diode laser transscleral ciliary body photocoagulation. Postoperative intraocular pressure, visual acuity and complications were observed and recorded. Results The visual acuity improved in 4 patients (8.3%), decreased in 2 patients (4.2%), and kept no change in 42 cases(87.5%) postoperatively. The success rates of IOP at 1 , 3 and 6 months after operation were 58.3%, 66.7% and 81.3% respectively, and the total effective rates were 89.6%, 93.8% and 95.9% respectively. No atrophy of eyeball, sclera melted or other serious postoperative complication happened. Conclusion Diode laser transscleral cyclophotocoagulation is safe and effective for the treatment of refractory glaucoma. Key words: Laser, diode; Cyclophotocoagulation, transscleral; Glaucoma, refractory

About this research paper

What this paper is about

Objective To evaluate the efficacy of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Methods The data of 48 eyes of 48 refractory glaucoma patients were enrolled and analyzed retrospectively. All eyes underwent diode laser transscleral ciliary body photocoagulation. Postoperative intraocular pressure, visual acuity and complications were observed and recorded. Results The visual acuity improved in 4 patients (8.3%), decreased in 2 patients (4.2%), and kept no change in 42 cases(87.5%) postoperatively. The success rates of IOP at 1 , 3 and 6 months after operation were 58.3%, 66.7% and 81.3% respectively, and the total effective rates were 89.6%, 93.8% and 95.9% respectively. No atrophy of eyeball, sclera melted or other serious postoperative complication happened. Conclusion Diode laser transscleral cyclophotocoagulation is safe and effective for the treatment of refractory glaucoma. Key words: Laser, diode; Cyclophotocoagulation, transscleral; Glaucoma, refractory

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Methods The data of 48 eyes of 48 refractory glaucoma patients were enrolled and analyzed retrospectively. All eyes underwent diode laser transscleral ciliary body photocoagulation. Postoperative intraocular pressure, visual acuity and complications were observed and recorded. Results The visual acuity improved in 4 patients (8.3%), decreased in 2 patients (4.2%), and kept no change in 42 cases(87.5%) postoperatively. The success rates of IOP at 1 , 3 and 6 months after operation were 58.3%, 66.7% and 81.3% respectively, and the total effective rates were 89.6%, 93.8% and 95.9% respectively. No atrophy of eyeball, sclera melted or other serious postoperative complication happened. Conclusion Diode laser transscleral cyclophotocoagulation is safe and effective for the treatment of refractory glaucoma. Key words: Laser, diode; Cyclophotocoagulation, transscleral; Glaucoma, refractory

Key concepts: Medicine, Refractory (planetary science), Sclera, Intraocular pressure, Ophthalmology, Glaucoma, Visual acuity, Ciliary body

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of transscleral laser cyclophotocoagulation for the treatment of refractory glaucoma — Research Paper | ScholarLens